Amid ongoing uncertainty over U.S. tariffs, India’s Department of Pharmaceuticals (DoP) is initiating a comprehensive study to revamp the logistics value chain of the pharmaceutical and medical devices sectors. According to a recent notification, the DoP will appoint a designated agency to conduct the study and formulate a detailed logistics plan aimed at strengthening India’s position as a global pharma and med-tech hub.The study will evaluate the current state of infrastructure, logistics practices, policies, and regulatory frameworks across the sectors. It will also propose actionable
The only supply chain registration you need
Unrivaled context behind every news and article for free.